The Use of FES-PET Imaging as a Tool to Detect a Possible Reversion of Estrogen Receptor (ER)-α Status in Patients With Metastatic Breast Cancer HER2 + and ERα Neg Treated With Trastuzumab + Pertuzumab + Taxane.
- Status
- TERMINATED
- Phase
- NA
Clinical Trials Related to HER2-positive Breast Cancer
Related studies linked through entity extraction aliases.
Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Neoadjuvant Study of Pyrotinib in Combination With Trastuzumab in Patients With HER2 Positive Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Impact of Pegfilgrastim on Trastuzumab Anti-tumor Effect and ADCC in Operable HER2+ Breast Cancer Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Trial to Compare the Safety, Efficacy and Immunogenicity of TX05 With Herceptin® in HER2+ Early Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
T-DM1 and Palbociclib for Metastatic HER2 Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Molecular Pathway Activation Markers Predicting Efficacy of Trastuzumab Therapy for HER2-positive Breast Cancer
- Status
- UNKNOWN
- Phase
- N/A
A Study of RC48-ADC Administered Intravenously to Patients With HER2-Positive Metastatic Breast Cancer With or Without Liver Metastases
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
Omission of Radiation in Patients With Her-2 Positive Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
HER2 Directed Dendritic Cell Vaccine During Neoadjuvant Therapy of HER2+Breast Cancer
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Vaccine to Prevent Recurrence in Patients With HER-2 Positive Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
PRS-343 in HER2-Positive Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
FATE-NK100 as Monotherapy and in Combination With Monoclonal Antibody in Subjects With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Study of ALT-P7 to Determine Safety, Tolerability and Pharmacokinetics in Breast Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE1
Randomized Trial of Neo-adjuvant Chemotherapy With or Without Metformin for HER2 Positive Operable Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
TVB-2640 and Trastuzumab With Paclitaxel or Endocrine Therapy for Treatment of HER2 Positive Metastatic Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
TCH Versus EC-TH as Neoadjuvant Treatment for HER2-Positive Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Margetuximab Expanded Access Program
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A
Clinical Trial of Atezolizumab With Paclitaxel, Trastuzumab, and Pertuzumab in Patients With Metastatic HER-2 Positive Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Phase I-II Study of Interferon-gamma in Patients With HER-2 Positive Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2